Please try another search
Cardio Diagnostics Holdings, Inc., an artificial intelligence-powered precision cardiovascular medicine company, develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease. The company was founded in 2017 and is headquartered in Chicago, Illinois.
Name | Age | Since | Title |
---|---|---|---|
Warren Hosseinion | 51 | 2022 | Non-Executive Chairman |
Meeshanthini V. Dogan | 34 | 2021 | Co-Founder, CEO & Director |
Robert A. Philibert | 61 | 2021 | Co-Founder, Chief Medical Officer & Director |
Oded Levy | 64 | 2022 | Independent Director |
Stanley K. Lau | 67 | 2022 | Independent Director |
Paul F. Burton | 56 | 2023 | Independent Director |
James Intrater | 59 | 2022 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review